L'Oreal SA
PAR:OR

Watchlist Manager
L'Oreal SA Logo
L'Oreal SA
PAR:OR
Watchlist
Price: 374.2 EUR -1.73% Market Closed
Market Cap: 199.9B EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one OR stock under the Base Case scenario is hidden EUR. Compared to the current market price of 374.2 EUR, L'Oreal SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OR Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

4.6
P/S
P/S
Price to Sales
4.6
vs History
82
vs Industry
10
Median 3Y
5.3
Median 5Y
5.4
Industry
1
Forward
4.2
More Details
31.2
P/E
P/E
Price to Earnings
31.2
vs History
85
vs Industry
18
Median 3Y
35.8
Median 5Y
38
Industry
16.4
Forward
27.9
More Details
24.1
P/OCF
P/OCF
Price to OCF
24.1
vs History
82
vs Industry
18
Median 3Y
29.6
Median 5Y
28.5
Industry
11.5
More Details
35.5
P/FCFE
P/FCFE
Price to FCFE
35.5
vs History
31
vs Industry
17
Median 3Y
31.7
Median 5Y
32.5
Industry
17.6
More Details
6
P/B
P/B
Price to Book Value
6
vs History
68
vs Industry
7
Median 3Y
7.4
Median 5Y
7.1
Industry
1.5
More Details
4.7
EV/S
EV/S
Enterprise Value to Sales
4.7
vs History
80
vs Industry
10
Median 3Y
5.3
Median 5Y
5.5
Industry
1.1
Forward
4.3
More Details
6.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.3
vs History
82
vs Industry
27
Median 3Y
7.2
Median 5Y
7.5
Industry
3.7
More Details
19.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.2
vs History
82
vs Industry
17
Median 3Y
22.1
Median 5Y
22.2
Industry
9.6
Forward
18
More Details
23.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
23.3
vs History
84
vs Industry
18
Median 3Y
27.2
Median 5Y
29.1
Industry
12.5
Forward
21.3
More Details
24.4
EV/OCF
EV/OCF
Enterprise Value to OCF
24.4
vs History
80
vs Industry
18
Median 3Y
29.9
Median 5Y
28.6
Industry
11.9
More Details
30.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
30.5
vs History
74
vs Industry
16
Median 3Y
37.5
Median 5Y
35
Industry
15.1
More Details
4.4
EV/IC
EV/IC
Enterprise Value to IC
4.4
vs History
74
vs Industry
11
Median 3Y
5.3
Median 5Y
5.2
Industry
1.2
More Details

Multiples Across Competitors

OR Competitors Multiples
L'Oreal SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
L'Oreal SA
PAR:OR
199.9B EUR 4.6 31.2 19.2 23.3
UK
Unilever PLC
LSE:ULVR
116.1B GBP 2.2 23.7 146.6 169.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.7 51 36.3 39.8
UK
HALEON PLC
LSE:HLN
34.2B GBP 3 23.7 14.1 15.9
DE
Beiersdorf AG
XETRA:BEI
26.8B EUR 2.7 29.3 12.4 15.1
US
Estee Lauder Companies Inc
NYSE:EL
21.3B USD 1.4 -30.7 11.2 17.6
JP
Kao Corp
TSE:4452
2.8T JPY 1.7 26.1 11.2 17.9
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 9.2 -286.1 42.2 45.3
CN
Giant Biogene Holding Co Ltd
HKEX:2367
79.3B HKD 13.4 36.1 27.9 28.4
IN
Dabur India Ltd
NSE:DABUR
858.9B INR 6.8 47.8 35.8 43.7
US
Bellring Brands Inc
NYSE:BRBR
9.6B USD 4.6 34.2 22.4 24.3
P/E Multiple
Earnings Growth PEG
FR
L'Oreal SA
PAR:OR
Average P/E: 33.7
31.2
9%
3.5
UK
Unilever PLC
LSE:ULVR
23.7
14%
1.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
51
8%
6.4
UK
HALEON PLC
LSE:HLN
23.7
13%
1.8
DE
Beiersdorf AG
XETRA:BEI
29.3
12%
2.4
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -30.7
43%
N/A
JP
Kao Corp
TSE:4452
26.1
10%
2.6
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
Negative Multiple: -286.1 N/A N/A
CN
G
Giant Biogene Holding Co Ltd
HKEX:2367
36.1
25%
1.4
IN
Dabur India Ltd
NSE:DABUR
47.8
9%
5.3
US
Bellring Brands Inc
NYSE:BRBR
34.2
17%
2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
L'Oreal SA
PAR:OR
Average EV/EBITDA: 34.5
19.2
7%
2.7
UK
Unilever PLC
LSE:ULVR
146.6
5%
29.3
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
36.3
7%
5.2
UK
HALEON PLC
LSE:HLN
14.1
5%
2.8
DE
Beiersdorf AG
XETRA:BEI
12.4
3%
4.1
US
Estee Lauder Companies Inc
NYSE:EL
11.2
4%
2.8
JP
Kao Corp
TSE:4452
11.2
7%
1.6
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
42.2
9%
4.7
CN
G
Giant Biogene Holding Co Ltd
HKEX:2367
27.9
22%
1.3
IN
Dabur India Ltd
NSE:DABUR
35.8
8%
4.5
US
Bellring Brands Inc
NYSE:BRBR
22.4
14%
1.6

See Also

Summary
OR intrinsic value, competitors valuation, and company profile.
DCF Valuation
OR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OR stock valuation using valuation multiples.
Wall Street Estimates
OR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 248,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.